Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $1,066 | 3 | 91.2% |
| Food and Beverage | $102.38 | 5 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tosoh Bioscience, Inc. | $1,066 | 3 | $0 (2018) |
| Chiesi USA, Inc. | $102.38 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.79 | 1 | Chiesi USA, Inc. ($17.79) |
| 2022 | $48.92 | 2 | Chiesi USA, Inc. ($48.92) |
| 2021 | $35.67 | 2 | Chiesi USA, Inc. ($35.67) |
| 2018 | $1,028 | 2 | Tosoh Bioscience, Inc. ($1,028) |
| 2017 | $38.00 | 1 | Tosoh Bioscience, Inc. ($38.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2022 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $27.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2022 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/29/2021 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2021 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/18/2018 | Tosoh Bioscience, Inc. | G8 Elution Buffer No. 1, 800mL (Medical Supply), G8 elution Buffer No. 2, 800mL, G8 Elution Buffer No. 3, 800mL | Gift | In-kind items and services | $514.00 | General |
| Category: Immunoassay | ||||||
| 01/18/2018 | Tosoh Bioscience, Inc. | G8 Elution Buffer No. 3, 800mL (Medical Supply), HEMOLYSIS/WASH SOL (2000 mL), SAMPLING NEEDLE ASSY - STD, G7,G8 | Gift | In-kind items and services | $514.00 | General |
| Category: Immunoassay | ||||||
| 04/25/2017 | Tosoh Bioscience, Inc. | HEMOLYSYS/WASH SOL (2000 mL) (Medical Supply) | Gift | In-kind items and services | $38.00 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 452 | 25,953 | $633,665 | $185,184 |
| 2022 | 14 | 502 | 22,090 | $567,010 | $161,815 |
| 2021 | 11 | 409 | 19,439 | $484,934 | $142,445 |
| 2020 | 10 | 337 | 6,259 | $204,055 | $62,048 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 42 | 25,400 | $406,400 | $124,473 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 210 | $72,660 | $20,566 | 28.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 16 | 55 | $42,228 | $9,799 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 56 | $29,392 | $8,294 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $25,389 | $6,497 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $23,310 | $5,497 | 23.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 40 | $17,600 | $5,370 | 30.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 11 | 29 | $7,250 | $2,089 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,492 | $1,762 | 27.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 17 | 18 | $1,224 | $296.28 | 24.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 20 | 20 | $1,220 | $295.60 | 24.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 25 | 29 | $500.00 | $243.60 | 48.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 39 | 21,510 | $344,160 | $101,920 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 180 | $62,280 | $16,991 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 74 | $34,854 | $10,687 | 30.7% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 16 | 50 | $37,145 | $8,649 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $34,188 | $8,478 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $24,087 | $5,998 | 24.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 11 | 26 | $11,440 | $3,568 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $7,574 | $2,385 | 31.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 12 | 27 | $6,734 | $2,080 | 30.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 27 | 27 | $1,647 | $401.61 | 24.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 17 | 17 | $1,156 | $281.18 | 24.3% |
| 86780 | Analysis for antibody, treponema pallidum | Office | 2022 | 11 | 11 | $792.00 | $143.82 | 18.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 39 | 40 | $480.00 | $118.44 | 24.7% |
About Dr. Scott Kaplan, M.D
Dr. Scott Kaplan, M.D is a Neurology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467680017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Kaplan, M.D has received a total of $1,168 in payments from pharmaceutical and medical device companies, with $17.79 received in 2023. These payments were reported across 8 transactions from 2 companies. The most common payment nature is "Gift" ($1,066).
As a Medicare-enrolled provider, Kaplan has provided services to 1,700 Medicare beneficiaries, totaling 73,741 services with total Medicare billing of $551,491. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Boston, MA
- Active Since 06/22/2009
- Last Updated 01/06/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467680017
Products in Payments
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $514.00
- G8 Elution Buffer No. 3, 800mL (Medical Supply) $514.00
- KENGREAL (Drug) $69.28
- HEMOLYSYS/WASH SOL (2000 mL) (Medical Supply) $38.00
- CLEVIPREX (Drug) $33.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boston
Christopher Wright, Md, MD
Neurology — Payments: $2.0M
Dr. Alfred Sandrock, Md Phd, MD PHD
Neurology — Payments: $1.2M
Thomas Scammell, M.d, M.D
Neurology — Payments: $598,925
Patrick Wen, Md, MD
Neurology — Payments: $583,963
Dr. Michael Levy, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $519,354
Roy Freeman, M.d, M.D
Neurology — Payments: $489,143